In under-resourced settings, an oncologist's role expands beyond clinical duties to include logistics, team leadership, fundraising, and crisis management. Medical training is insufficient; they also need skills in negotiation, management, and leadership to run a functional care unit.
Related Insights
Despite a PhD in the molecular biology of lung cancer, Dr. Manley's career shifted to health equity. This wasn't a planned transition but a direct response to seeing his family's healthcare struggles and requests from underserved patient communities, showing how personal experience can create new professional missions.
A single solution is insufficient to address the financial toxicity of cancer. A multi-pronged strategy is required: clinical-level financial screening and literacy education, employer-level workplace accommodations to facilitate return-to-work, and governmental-level policy changes like tax breaks or fiscal stimulus for survivors.
The core job of a scientist isn't knowing facts, but figuring out what's unknown. This problem-solving 'toolbox'—how to think, act, and work with teams to tackle new problems—is directly transferable to the CEO role, enabling leaders to navigate unfamiliar domains like corporate finance or legal structures.
To transform the complex healthcare industry, product leaders need three key skills. First, use first-principles thinking to deconstruct customer problems. Second, master storytelling to inspire change in large organizations, as data alone is insufficient. Third, evaluate performance on concrete financial, operational, and outcome-based metrics.
Successful drug launches hinge on executional excellence, which is driven by soft skills like listening, effective communication, and building cross-functional alignment. Analytical strategy alone is insufficient if it cannot be translated into action by the team on the ground.
Beyond technological and regulatory hurdles, a crucial barrier to healthcare innovation is complacency within leadership. Executives must be more curious and proactive in understanding emerging technologies to drive meaningful change.
The transition from a resource-rich environment like Novartis to an early-stage biotech reveals a stark contrast. The unlimited access to a global organization is replaced by a total reliance on a small, nimble team where everyone must be multi-skilled and hands-on, a change even experienced executives find jarring.
A successful research program requires deep integration with the clinical environment. By spending time with oncologists and nurses and joining tumor boards, scientists gain the necessary context to ask the most meaningful questions, bridging the gap between theoretical lab work and the reality of patient care.
Luba Greenwood argues that unlike in tech, many biotech CEOs lack P&L experience. In today's cash-constrained market, CEOs need to be able to build financial models and understand finance deeply to be effective, a skill she personally developed after transitioning from law and science.
A primary driver of physician burnout isn't the difficulty of medicine but the overwhelming administrative load. Talented doctors are leaving the profession because their time is consumed by paperwork and fighting with insurance companies, creating a huge opportunity for automation.
